For patients with chronic pain, opioid use disorder (OUD) is characterized by difficulties in positive emotion regulation (ER), and mindfulness training can enhance positive ER.

Nirsevimab is effective for reducing the burden of respiratory syncytial virus (RSV) in infants in real-world settings.